News | PET-MRI | November 08, 2018

Researcher Awarded 2018 Hitachi Healthcare Americas/RSNA Grant

 

 

David Schultz, M.D., Ph.D.

David Schultz, M.D., Ph.D.

The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation awarded the 2018 Hitachi Healthcare Americas/RSNA Research Seed Grant to David Shultz, M.D., Ph.D. This grant is made possible by Hitachi Healthcare Americas’ support of the RSNA R&E Foundation. The Hitachi Healthcare Americas/RSNA Research Seed Grant provides $40,000 for a one-year project to test hypotheses and obtain pilot data in preparation for major grant applications. David Shultz, M.D., Ph.D., Princess Margaret Cancer Centre, with scientific advisor Patrick VeitHaibach, M.D., will use FAZA-PET/MRI to identify hypoxic tumor in patients with localized high-risk sarcoma. Dr. Shultz and his team will also use pimonidazole, a molecular probe for hypoxia, to validate the FAZA results and further characterize the biologic features of hypoxic tumors. The ultimate goal of this work is to determine if hypoxia imaging with PET/MRI improves the management of sarcoma and to evaluate and characterize hypoxic mechanisms on a molecular level within clinical specimens. Through these efforts, they seek to improve the ability to treat patients with high-risk sarcoma. The RSNA R&E Foundation Board of Trustees approved funding for $4 million in radiology research and education grants this year, achieving a funding rate of 35 percent of grant applicants. “The R&E Foundation is grateful for Hitachi Healthcare Americas’ support of the 2018 grant recipients. This longstanding partnership and commitment is a vital component in ensuring research innovation and seeding the future of radiology,” said N. Reed Dunnick, M.D., chair of the R&E Foundation Board of Trustees. 

For more information: www.rsna.org

Related Content

RamSoft
News | Information Technology | November 18, 2019
November 18, 2019 — A recent report by security firm Emsisoft stated that
 Prostate cancer MRI
News | Clinical Trials | November 15, 2019
November 15, 2019 — Theragnostics, which is developing innovative radiopharm
Image by Pexels from Pixabay RSNA 2019

Image by Pexels from Pixabay 

News | RSNA | November 15, 2019
November 15, 2019 – The 105th Scientific Assembly and Annual Meeting of the...

Guerbet presented its Contrast&Care injection management solution at ECR 2018

News | Contrast Media | November 13, 2019
November 13, 2019 – Guerbet, a global specialist in...
Mindray announced its partnership with Cincinnati Children's Hospital Medical Center, one of the top children's hospitals in the United States
News | Ultrasound Imaging | November 13, 2019
November 13, 2019 – Mindray announced its partnership with...
 MaxQ AI
News | Artificial Intelligence | November 13, 2019
November 13, 2019 – MaxQ AI announced a new partnership agreement with...
An image on Brigham and Women's Hospital's 7T MRI system

An image on Brigham and Women's Hospital's 7T MRI system. Image courtesy of Brigham and Women's Hospital

News | Magnetic Resonance Imaging (MRI) | November 13, 2019
November 13, 2019 — Increased immune system activity along the surface of the brain, or meningeal inflammation, may b
 Paxera Ultima 360
News | Enterprise Imaging | November 12, 2019
November 12, 2019 — Medical Imaging developer PaxeraHealth will showcase the